🇺🇸 FDA
Patent

US 9523079

Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes

granted A61KA61K31/7105A61K38/00

Quick answer

US patent 9523079 (Cardiac repair by reprogramming of cardiac fibroblasts into cardiomyocytes) held by The Board of Regents of the University of Texas System expires Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/7105, A61K38/00, A61K38/17, A61K45/06